Vicarious Surgical reports Q1 2024 net loss of $17.0M; cash burn guidance unchanged at $50M

Vicarious Surgical Inc.

2024-Q1 EPS reported -$0.10

GAAP net loss $17.0M ($0.10/sh) vs $26.9M ($0.21) YoY; adjusted net loss $15.1M ($0.09).
Operating expenses fell 28% to $16.1M from $22.3M; R&D $10.0M, G&A $5.0M, S&M $1.1M.
Cash & investments $84.1M; Q1 cash burn $14.1M; FY 2024 cash burn guidance reaffirmed at ~$50M.
Completed spring cadaver lab; refining V1.0 system ahead of final integration in fall 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

Vicarious Surgical Inc. reported the quarter ended March 31, 2024 results: net income GAAP net loss for the first quarter was $17.0 million, equating to a net loss per share of $0.10, EPS $0.10. Guidance reaffirmed.

Period: the quarter ended March 31, 2024
Net income: GAAP net loss for the first quarter was $17.0 million, equating to a net loss per share of $0.10
EPS: $0.10
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Vicarious Surgical Reports First Quarter 2024 Financial Results

View on SEC.gov

Browse all earnings releases →

Vicarious Surgical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-037162

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.